The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Liposomal Drug Delivery Systems and Anticancer Drugs
Open accessAbstract
Cancer is a life-threatening disease contributing to ~3.4 million deaths worldwide. There are various causes of cancer, such as smoking, being overweight or obese, intake of processed meat, radiation, family history, stress, environmental factors, and chance. The first-line treatment of cancer is the surgical removal of solid tumours, radiation therapy, and chemotherapy. The systemic administration of the free drug is considered to be the main clinical failure of chemotherapy in cancer treatment, as limited drug concentration reaches the tumour site. Most of the active pharmaceutical ingredients (APIs) used in chemotherapy are highly cytotoxic to both cancer and normal cells. Accordingly, targeting the tumour vasculatures is essential for tumour treatment. In this context, encapsulation of anti-cancer drugs within the liposomal system offers secure platforms for the targeted delivery of anti-cancer drugs for the treatment of cancer. This, in turn, can be helpful for reducing the cytotoxic side effects of anti-cancer drugs on normal cells. This short-review focuses on the use of liposomes in anti-cancer drug delivery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Liposome: classification, preparation, and applications
Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., & Nejati-Koshki, K. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-102 · Cited by 3,632
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Advances and Challenges of Liposome Assisted Drug Delivery
Sercombe, L., Veerati, T., Moheimani, F., Wu, S. Y., Sood, A. K., & Hua, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00286 · Cited by 2,632
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II
Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. D., & Liu, L. F. (1984) · Science · doi:10.1126/science.6093249 · Cited by 1,538
Nishida, N., Yano, H., Nishida, T., Kamura, T., & Kojiro, M. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.213 · Cited by 1,434
The function of sterols in membranes
Demel, R. A., & De Kruyff, B. (1976) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(76)90008-3 · Cited by 1,341
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
Drummond, D. C., Meyer, O., Hong, K., Kirpotin, D. B., & Papahadjopoulos, D. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01426-1 · Cited by 1,263
Wang-Gillam, A., Li, C.-P., Bodoky, G., Dean, A., Shan, Y.-S., Jameson, G., Macarulla, T., Lee, K.-H., Cunningham, D., Blanc, J. F., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00986-1 · Cited by 1,222 · cited 2×
“Irinotecan Pancreatic ductal adenocarcinoma [100]”
BackgroundPaclitaxel and its formulations
Singla, A. K., Garg, A., & Aggarwal, D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00986-3 · Cited by 1,100
Design of Liposomes for Enhanced Local Release of Drugs by Hyperthermia
Yatvin, M. B., Weinstein, J. N., Dennis, W. H., & Blumenthal, R. (1978) · Science · doi:10.1126/science.364652 · Cited by 956
Influence of cholesterol on liposome stability and on in vitro drug release
Briuglia, M.-L., Rotella, C., McFarlane, A., & Lamprou, D. A. (2015) · Drug Delivery and Translational Research · doi:10.1007/s13346-015-0220-8 · Cited by 740
Liposomes as immunological adjuvants
ALLISON, A. C., & GREGORIADIS, G. (1974) · Nature · doi:10.1038/252252a0 · Cited by 675
Fate and behavior of liposomes in vivo: a review of controlling factors.
Senior, J. H. (1987) · PubMed · Cited by 591
Dawidczyk, C. M., Kim, C., Park, J. H., Russell, L. M., Lee, K. H., Pomper, M. G., & Searson, P. C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.036 · Cited by 527
Liposomes as vaccine delivery systems: a review of the recent advances
Schwendener, R. A. (2014) · Therapeutic Advances in Vaccines · doi:10.1177/2051013614541440 · Cited by 525
The role of gelatinases in colorectal cancer progression and metastasis
Mook, O. R. F., Frederiks, W. M., & Van Noorden, C. J. F. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.09.006 · Cited by 511
Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review
Riaz, M., Riaz, M., Zhang, X., Lin, C., Wong, K., Chen, X., Zhang, G., Lu, A., & Yang, Z. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010195 · Cited by 509
Kong, G., Anyarambhatla, G., Petros, W. P., Braun, R. D., Colvin, O. M., Needham, D., & Dewhirst, M. W. (2000) · PubMed · Cited by 505
Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects
Kunjachan, S., Ehling, J., Storm, G., Kiessling, F., & Lammers, T. (2015) · Chemical Reviews · doi:10.1021/cr500314d · Cited by 480
Long-circulating (sterically stabilized) liposomes for targeted drug delivery
Allen, T. M. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90314-x · Cited by 445
Gill, P. S., Wernz, J., Scadden, D. T., Cohen, P., Mukwaya, G. M., von Roenn, J. H., Jacobs, M., Kempin, S., Silverberg, I., Gonzales, G., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.8.2353 · Cited by 438
Semple, S. C., Chonn, A., & Cullis, P. R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00128-2 · Cited by 402
Cathepsin B as a cancer target
Gondi, C. S., & Rao, J. S. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.740461 · Cited by 399
Mohammed, A. R., Weston, N., Coombes, A. G. A., Fitzgerald, M., & Perrie, Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.07.010 · Cited by 386
Liposomes and Local Hyperthermia: Selective Delivery of Methotrexate to Heated Tumors
Weinstein, J. N., Magin, R. L., Yatvin, M. B., & Zaharko, D. S. (1979) · Science · doi:10.1126/science.432641 · Cited by 363
Ball, R., Bajaj, P., & Whitehead, K. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s123062 · Cited by 333 · cited 1×
“Several methods are available that show extendable techniques to stabilise the liposomal formulations, such as lyophilization [42], spray drying [43], and supercritical fluid [44].”
MethodA review of the development of tumor vasculature and its effects on the tumor microenvironment
Forster, J., Harriss-Phillips, W., Douglass, M., & Bezak, E. (2017) · Hypoxia · doi:10.2147/hp.s133231 · Cited by 313
Cholesterol modulates the liposome membrane fluidity and permeability for a hydrophilic molecule
Kaddah, S., Khreich, N., Kaddah, F., Charcosset, C., & Greige-Gerges, H. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.01.017 · Cited by 308
Oral protein delivery: Current status and future prospect
Park, K., Kwon, I. C., & Park, K. (2011) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2010.10.002 · Cited by 266
Advantages of liposomal delivery systems for anthracyclines
Allen, T. M., & Martin, F. J. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.08.001 · Cited by 248
Invasion and metastasis in pancreatic cancer.
Keleg, S., Büchler, P., Ludwig, R., Büchler, M. W., & Frieß, H. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-14 · Cited by 222
Maeda, H., Noguchi, Y., Sato, K., & Akaike, T. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02362.x · Cited by 221
Zhou, J., Zhao, W.-Y., Ma, X., Ju, R.-J., Li, X.-Y., Li, N., Sun, M.-G., Shi, J.-F., Zhang, C.-X., & Lu, W.-L. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.078 · Cited by 216
Possibility of active targeting to tumor tissues with liposomes
Maruyama, K., Ishida, O., Takizawa, T., & Moribe, K. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00042-3 · Cited by 211
Gaber, M. H., Hong, K., Huang, S. K., & Papahadjopoulos, D. (1995) · Pharmaceutical Research · doi:10.1023/a:1016206631006 · Cited by 206
Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera
Rocca, G. L., Pucci-Minafra, I., Marrazzo, A., Taormina, P., & Minafra, S. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601725 · Cited by 197
Surapaneni, M. S., Das, S. K., & Das, N. G. (2012) · ISRN Pharmacology · doi:10.5402/2012/623139 · Cited by 179
Enzyme-Responsive Liposomes for the Delivery of Anticancer Drugs
Fouladi, F., Steffen, K. J., & Mallik, S. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00736 · Cited by 177
Targeting of Tumor Cells by Cell Surface Urokinase Plasminogen Activator-dependent Anthrax Toxin
Liu, S., Bugge, T. H., & Leppla, S. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011085200 · Cited by 168
Involvement of the Kinin‐generating Cascade in Enhanced Vascular Permeability in Tumor Tissue
Matsumura, Y., Kimura, M., Yamamoto, T., & Maeda, H. (1988) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1988.tb01563.x · Cited by 163
Tahover, E., Patil, Y. P., & Gabizon, A. A. (2015) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000182 · Cited by 160
Cardiac Safety of Liposomal Anthracyclines
Safra, T. (2003) · The Oncologist · doi:10.1634/theoncologist.8-2004-17 · Cited by 153
Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation
Kumar, A., Chen, F., Mozhi, A., Zhang, X., Zhao, Y., Xue, X., Hao, Y., Zhang, X., Wang, P. C., & Liang, X. (2013) · Nanoscale · doi:10.1039/c3nr01525d · Cited by 152
Yamashita, S.-I., Yamashita, J.-I., & Ogawa, M. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.229 · Cited by 147
Xu, X., Wang, L., Xu, H.-Q., Huang, X., Qian, Y.-D., & Xiang, J. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.4.2591 · Cited by 144
Pharmacokinetics and Pharmacodynamics of Lipidic Nano-Particles in Cancer
Allen, T. M., Cheng, W., Hare, J. I., & Laginha, K. M. (2006) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152006778699121 · Cited by 143
Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade.
Graff, J. R., Konicek, B. W., Deddens, J. A., Chedid, M., Hurst, B. M., Colligan, B. M., Neubauer, B. L., Carter, H. W., & Carter, J. H. (2001) · PubMed · Cited by 136
Maeda, H., Matsumura, Y., & Kato, H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37555-0 · Cited by 130
Liposomal daunorubicin as treatment for Kaposi’s sarcoma
Dittmer, D. P., & Petre, C. E. (2007) · PubMed Central · doi:10.17615/wyf0-9n94 · Cited by 130
Alderton, P., Gross, J., & Green, M. D. (1992) · PubMed · Cited by 120
European Perspective on the Costs and Cost-Effectiveness of Cancer Therapies
Drummond, M., & Mason, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.8956 · Cited by 120
Pharmacokinetics and Metabolism of Mitoxantrone
Ehninger, G., Schuler, U. S., Proksch, B., Zeller, K., & Blanz, J. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199018050-00003 · Cited by 112
Magnetic liposomes for colorectal cancer cells therapy by high-frequency magnetic field treatment
Hardiansyah, A., Huang, L., Yang, M., Liu, T.-Y., Tsai, S.-C., Yang, C., Kuo, C., Chan, T., Zou, H.-M., Lian, W.-N., et al. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-497 · Cited by 112
Denmeade, S. R., Sokoll, L. J., Chan, D. W., et al. (2001) · The Prostate · doi:10.1002/pros.1075 · Cited by 110
Influence of Lipid Composition and Ionic Strength on the Physical Stability of Liposomes
Crommelin, D. J. A. (1984) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600731118 · Cited by 109
Kono, K., Zenitani, K.-I., & Takagishi, T. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90325-5 · Cited by 108
Yamashita, S., Yamashita, J.-I., Sakamoto, K., Inada, K., Nakashima, Y., Murata, K., Saishoji, T., Nomura, K., & Ogawa, M. (1993) · Cancer · doi:10.1002/1097-0142(19930515)71:10<3058::aid-cncr2820711028>3.0.co;2-8 · Cited by 107
Dumalaon-Canaria, J. A., Hutchinson, A. D., Prichard, I. J., & Wilson, C. J. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0377-3 · Cited by 106
Liposomes as Immunological Adjuvants
ALLISON, A. C., & Gregoriadis, G. (1976) · Springer eBooks · doi:10.1007/978-3-642-81049-7_8 · Cited by 104
Delivery of Nanoparticles for Treatment of Brain Tumor
Chen, K., Sun, Y., Zhu, J., Li, W., Zhang, A., Kuang, T., Xie, J., & Yang, Z. (2016) · Current Drug Metabolism · doi:10.2174/1389200217666160728152939 · Cited by 103
Balzus, B., Sahle, F. F., Hönzke, S., Gerecke, C., Schumacher, F., Hedtrich, S., Kleuser, B., & Bodmeier, R. A. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.02.001 · Cited by 99
Liposomes: Targeted and Controlled Delivery System
Garg, T., & Goyal, A. K. (2013) · Drug Delivery Letters · doi:10.2174/22103031113036660015 · Cited by 97
Sustained release of acyclovir from nano-liposomes and nano-niosomes: an in vitro study.
Mukherjee, B., Patra, B., Layek, B., & Mukherjee, A. (2007) · PubMed · Cited by 94
Hwang, S., Karn, P. R., Cho, W., Park, H. J., & Park, J. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s39025 · Cited by 88
Patil-Gadhe, A., & Pokharkar, V. (2013) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2013.07.006 · Cited by 83
Stability Aspects of Liposomes
Yadav, A. V., Murthy, M. S., Shete, A. S., & Sakhare, S. S. (2011) · Cited by 80
Anticancer activity of all- trans retinoic acid-loaded liposomes on human thyroid carcinoma cells
Cristiano, M. C., Cosco, D., Celia, C., Tudose, A., Mare, R., Paolino, D., & Fresta, M. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.10.052 · Cited by 80
Liposome as a Carrier for Advanced Drug Delivery
Shaheen, S. M., ., F. R. S. A., Hossen, M. N., et al. (2006) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2006.1181.1191 · Cited by 76
Neutrophil Elastase as a Target in Lung Cancer
Moroy, G., Alix, A. J. P., Sápi, J., Hornebeck, W., & Bourguet, E. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012800617696 · Cited by 73
Arnold, R. D., Mager, D. E., Slack, J. E., & Straubinger, R. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1365 · Cited by 69
The Effects of Lyophilization on the Physico-Chemical Stability of Sirolimus Liposomes
Ghanbarzadeh, S., Valizadeh, H., & Zakeri‐Milani, P. (2013) · Europe PMC (PubMed Central) · doi:10.5681/apb.2013.005 · Cited by 68
Liu, W., Fuqiang, W., Ye, A., Tian, M., & Han, J. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2017.03.021 · Cited by 64
Mock, J. N., Costyn, L. J., Wilding, S. L., Arnold, R. D., & Cummings, B. S. (2012) · Integrative Biology · doi:10.1039/c2ib20108a · Cited by 63
Gogoi, M., Jaiswal, M. K., Sarma, H. D., Bahadur, D., & Banerjee, R. (2017) · Integrative Biology · doi:10.1039/c6ib00234j · Cited by 60
Yamashita, J., Ogawa, M., & Shirakusa, T. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.3.375 · Cited by 56
Takechi‐Haraya, Y., Goda, Y., & Sakai‐Kato, K. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00051 · Cited by 54
Immunohistochemical localization of group II phospholipase A2 in human pancreatic carcinomas
Kiyohara, H., Egami, H., Kako, H., Shibata, Y., Murata, K., Ohshima, S., Sei, K., Suko, S., KURANO, R., & Ogawa, M. (1993) · International Journal of Pancreatology · doi:10.1007/bf02795199 · Cited by 52
Ferguson, H. M., Chan, D., Sockolosky, J. T., Finney, L. A., Maxey, E., Vogt, S., & Szoka, F. C. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.03.003 · Cited by 52
Inhibition of Neutrophil Elastase Suppresses the Development of Skin Tumors in Hairless Mice
STARCHER, B. C., O’Neal, P., Granstein, R. D., & Beissert, S. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12329559 · Cited by 49
Matsuo, H., Wakasugi, M., Takanaga, H., Ohtani, H., Naito, M., TSURUO, T., & Sawada, Y. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00460-6 · Cited by 48
Čeh, B., & Lasiç, D. D. (1997) · Journal of Colloid and Interface Science · doi:10.1006/jcis.1996.4555 · Cited by 46
Nanosized Camptothecin Conjugates for Single and Combined Drug Delivery
Chen, K., Sun, Y., Wang, M., & Cheng, X. (2016) · European Journal of BioMedical Research · doi:10.18088/ejbmr.2.1.2016.pp8-14 · Cited by 42
Hooper, L., Anderson, A., Birch, J., Forster, A., Rosenberg, G., Bauld, L., & Vohra, J. (2017) · Journal of public health · doi:10.1093/pubmed/fdx145 · Cited by 42
Munye, M. M., Ravi, J., Tagalakis, A. D., McCarthy, D., Ryadnov, M. G., & Hart, S. L. (2015) · Scientific Reports · doi:10.1038/srep09292 · Cited by 39
Lipka, D., Legut, M., Filipczak, N., Gubernator, J., Piwoni, A., & Kozubek, A. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s54911 · Cited by 35
Licaj, I., Jacobsen, B. K., Selmer, R. M., Maskarinec, G., Weiderpass, E., & Gram, I. T. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.418 · Cited by 32
Grace, V. M. B., & Viswanathan, S. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.04.005 · Cited by 32
Fumagalli, L. A. M., Zucchetti, M., Parisi, I., Viganò, M. G., Zecca, B., Careddu, A., D’Incalci, M., & Lazzarin, A. (2000) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051025 · Cited by 31
Kucherov, F. A., Egorova, K. S., Posvyatenko, A. V., Eremin, D. B., & Ananikov, V. P. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b03568 · Cited by 31
Sp, O., Ganusevich, І. І., Bubnovskaya, L., Valkovskaya, N., Kovelskaya, A., Tk, S., & Sv, Z. (2005) · PubMed · Cited by 29
Multifunctional Magnetic Liposomes for Cancer Imaging and Therapeutic Applications
Gogoi, M., Kumar, N., & Patra, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-47347-7.00027-6 · Cited by 29
Revenco, T., Lapouge, G., Moers, V., Brohée, S., & Sotiropoulou, P. A. (2017) · Stem Cells · doi:10.1002/stem.2571 · Cited by 20
Breast tumor DNA methylation patterns associated with smoking in the Carolina Breast Cancer Study
Conway, K., Edmiston, S. N., Parrish, E., Bryant, C., Tse, C., Swift‐Scanlan, T., McCullough, L. E., & Kuan, P. F. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4178-8 · Cited by 20
Cited by
Liposomes: Structure, composition, types, and clinical applications
Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09394 · Cited by 1,561
Design of liposomes as drug delivery system for therapeutic applications
Guimarães, D., Cavaco-Paulo, A., & Nogueira, E. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120571 · Cited by 1,196
Magnetic Nanoparticles in Cancer Therapy and Diagnosis
Farzin, A., Etesami, S. A., Quint, J., Memic, A., & Tamayol, A. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901058 · Cited by 562
Nanomedicine review: clinical developments in liposomal applications
Beltrán-Gracia, E., López-Camacho, A., Higuera-Ciapara, I., Velázquez-Fernández, J. B., & Vallejo-Cardona, A. A. (2019) · Cancer Nanotechnology · doi:10.1186/s12645-019-0055-y · Cited by 513
siRNA: Mechanism of action, challenges, and therapeutic approaches
Alshaer, W., Zureigat, H., Al Karaki, A., Al-Kadash, A., Gharaibeh, L., Hatmal, M. M., Aljabali, A. A. A., & Awidi, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174178 · Cited by 441
Metadata
- Authors
- Olusanya, T., Haj Ahmad, R., Ibegbu, D., Smith, J., & Elkordy, A.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2018-04-14
- Volume
- 23
- Issue
- 4
- Pages
- 907
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2797455782
- Cited by
- 603
- References
- 98
- FWCI
- 14.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.